Explore Our Refreshed and Expanded Clinical Trials Database ACPMP is excited to announce a significant update to our Clinical Trials Database – an important resource for physicians and their patients seeking clinical trials for appendix cancer. This update is part of our larger effort to provide the appendix cancer community with the most current and comprehensive information available. Here are...

The Appendix Cancer PMP Research Foundation (ACPMP) proudly announces the publication of a landmark article in Nature Reviews Cancer entitled “Defining a 'cells to society' research framework for appendiceal tumors.” This pivotal Expert Recommendation, officially published online on February 20, is the direct result of the Appendix Cancer PMP Research Foundation Scientific Think Tank—an innovative, multidisciplinary gathering designed to advance...

Thanks to the generosity of our donors, ACPMP is proud to fund two 2025 Society of Surgical Oncology (SSO) research grants focused solely on appendix cancer and PMP—including a significant new award in memory of our founder. SSO advances cancer research by providing research funding through its competitive Clinical Investigator and Young Investigator Awards programs. Introducing the Lisa Kurtz Luciano Appendix Cancer and Pseudomyxoma...

New research from MD Anderson Cancer Center, led by Dr. John Paul Shen – a member of ACPMP's Medical Advisory Board – finds that BRAF-mutant appendix cancer responds to BRAF-targeted therapy. The study was published in npj Precision Oncology. Why this research was needed Appendiceal adenocarcinoma is rare, and treatment options are limited. Historically, it has been treated with the...

Scientists have long known that cancer cells consume glucose to fuel their growth. The relationship between fructose and cancer growth, however, has been less clear – until now. A new NIH-funded study published in Nature reveals an unexpected way fructose can help tumors grow. What the study found In laboratory animal models, both fructose and high-fructose corn syrup accelerated the...

A new study published in Clinical Cancer Research takes a close look at circulating tumor DNA (ctDNA) in appendix cancer. ctDNA is made up of small fragments of tumor DNA that can be found in the bloodstream, and blood tests that detect it (sometimes called "liquid biopsies") are increasingly used in cancer care. What the researchers found The study found...

$50,000 Grant Awarded to Dr. Andrew Lowy for Groundbreaking Research on Mucinous Appendix Cancer SPRINGFIELD, PA, UNITED STATES, December 19, 2024 /EINPresswire.com/ -- The Appendix Cancer PMP Research Foundation (ACPMP) is pleased to announce a historic achievement: the launch of a second Catalyst Research Grant cycle within the same year, culminating in the funding of a third $50,000 research grant in 2024....

Researchers at UC San Diego have found that palbociclib, a breast cancer drug, shows promise for treating a rare form of appendix cancer called peritoneal mucinous carcinomatosis (PMC). Dr. Andrew Lowy, co-senior author and ACPMP Medical Advisory Board Member, says, "Finding that a breast cancer drug is successful in treating a subset of appendix cancer — where treatment options are...

We are thrilled to announce that ACPMP is funding a significant new $100,000 grant this year: The Lisa Kurtz Luciano Appendix Cancer and Pseudomyxoma Peritonei Clinical Investigator Award! Thanks to all of our supporters and their donations, ACPMP is pleased to be able to fund this Society of Surgical Oncology (SSO) award focused solely on appendix cancer and PMP. Named...

The Appendix Cancer Pseudomyxoma Peritonei (ACPMP) Research Foundation is pleased to announce the recipients of our 2021 research grant cycle. Thank you as always to our incredible, dedicated supporters, fundraisers, and donors for making these grants happen. And thank you to the many researchers who applied to our research grant program and to all of the scientific community engaged in...